Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2019 Jul-Sep;33(3):260–265. doi: 10.1097/WAD.0000000000000317

Table 1.

Patient Characteristics by Diagnostic Group

bvFTH nfvPPA svPPA CBS PSP-S AD Statistics and P value
n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD)

Age 156 60.94 (8.50)b,d,e,f, 38 66.47 (9.93)a 72 63.50 (6.58)e 49 65.51 (8.57)a 45 68.82 (7.29)a,c 123 66.93 (10.78)a F(1,5)= 9.59, p<.001
Gender (M/F) 156 94/62 38 14/24 72 36/36 49 21/28 45 22/23 123 56/67 χ2(5, N=483)=11.18, p<.05
MMSE 152 21.84 (7.51)e 35 23.53 (7.32)f 69 22.17 (7.54) 46 24.33 (4.99)f 43 25.42 (4.73)a,f 111 20.80 (5.98)b,d,e F(1,5)= 4.77, p<.001
CDR 152 1.33 (0.74)b,c,d,e,f 36 0.51 (0.41)a,f 72 0.78 (0.52)a 44 0.72 (0.59)a 43 0.87 (0.67)a 118 0.89 (0.42)a,b F(1,5)= 19.32, p<.001
CDR-SB 152 7.50 (3.63) b,c,d,e,f 36 2.17 (2.04)a,c,e,f 72 4.34 (3.12)a,b 44 3.57 (3.29)a 43 4.84 (3.78)a,b 118 4.95 (2.50)a,b F(1,5)= 26.02, p<.001
NPI 149 45.76 (21.39) b,c,d,e,f 33 12.58 (13.68)a,c,e 69 31.49 (19.95)a,b,d,f 45 22.96 (16.47)a,c 42 29.26 (18.80)a,b 45 19.07 (16.30)a,c F(1,5)= 29.27, p<.001
IRI-EC 134 18.78 (6.53) b,c,d,e,f 34 25.47 (5.02)a 64 22.92 (7.68)a,f 41 23.78 (7.07)a 40 23.95 (7.07)a 110 26.79 (5.16)a,c F(1,5)= 20.69, p<.001
IRI-PT 133 12.21 (5.34) b,c,d,e,f 34 21.44 (5.44)a,c 65 15.42 (6.72)a,b,e,e 41 19.27 (6.32)a 41 20.29 (7.13)a,c, 110 19.05 (6.14)a,c F(1,5)= 26.25, p<.001

All variables were derived from the first available time point. Continuous variables compared by ANOVA with post-hoc pairwise Dunnett’s T3 tests. Gender compared by chi square.

a

p <.05 versus bvFTD group

b

p <.05 versus nfvPPA group

c

p <.05 versus svPPA group

d

p <.05 versus CBS group

e

p <.05 versus PSP-S group

f

p <.05 versus AD group.

MMSE, Mini-Mental State Examination; CDR, Clinical Dementia Rating; CDR-SB, CDR sum of boxes; NPI, Neuropsychiatric Inventory; IRI, Interpersonal Reactivity Index; EC, empathic concern; PT, perspective taking.